Related references
Note: Only part of the references are listed.Cardiovascular Biomarkers in Groups of Established Smokers after a Decade of Smoking
Gioacchino Calapai et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers
Frazer J. Lowe et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Population estimates for biomarkers of exposure to cigarette smoke in adult US cigarette smokers
Hans J. Roethig et al.
NICOTINE & TOBACCO RESEARCH (2009)
The relationship between smoking machine derived tar yields and biomarkers of exposure in adult cigarette smokers in the US
Paul Mendes et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors
Goodarz Danaei et al.
PLOS MEDICINE (2009)
A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system
Hans J. Roethig et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Characterisation of smoking behaviour across the life course and its impact on decline in lung function and all-cause mortality: evidence from a British birth cohort
S. Clennell et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2008)
Effects of cigarette smoking on hematological parameters and von Willebrand factor functional activity levels in asymptomatic male and female Arab smokers
Anwar M. Al-Awadhi et al.
MEDICAL PRINCIPLES AND PRACTICE (2008)
Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon-filtered cigarettes in short-term and long-term clinical studies
Mohamadi Sarkar et al.
NICOTINE & TOBACCO RESEARCH (2008)
Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers
Kimberly Frost-Pineda et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2008)
Active smoking and the risk of type 2 diabetes - A systematic review and meta-analysis
Carole Willi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Biomarkers of exposure and potential harm in adult smokers of 3-7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers
B. K. Zedler et al.
BIOMARKERS (2006)
An approach to the validation of biomarkers of harm for use in a tobacco context
EO Gregg et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2006)
Impact of increased heart rate on clinical outcomes in hypertension - Implications for antihypertensive drug therapy
P Palatini et al.
DRUGS (2006)
Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking
HJ Roethig et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Cigarette smoking and infection
L Arcavi et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Elevated heart rate: A major risk factor for cardiovascular disease
P Palatini et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2004)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Smoking, low density lipoprotein cholesterol, fibrinogen and myocardial infarction before 41 years of age: A Danish case-control study
FE von Eyben et al.
JOURNAL OF CARDIOVASCULAR RISK (2002)
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
JW Eikelboom et al.
CIRCULATION (2002)
Smoking, other risk factors and fibrinogen levels: Evidence of effect modification
M Tuut et al.
ANNALS OF EPIDEMIOLOGY (2001)
Social determinants of von Willebrand factor - The Whitehall II Study
M Kumari et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Isoprostanes: new markers of oxidative stress. Fundamental and clinical data
JL Cracowski et al.
REVUE DE MEDECINE INTERNE (2000)
Measurement of F2-isoprostanes as an index of oxidative stress in vivo
LJ Roberts et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Share Paper
